Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A combination of TERT promoter mutation and MGMT methylat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
0
Authors
Hideyuki Arita
52 more
Hideyuki Arita
•
Kaori Suzuki
50 more
•
Koichi Ichimura
Published
August 8, 2016
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Acta Neuropathologica Communications
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1186/s40478-016-0351-2
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Acta Neuropathologica Communications
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1186/s40478-016-0351-2
License
CC-BY
